Dashboard
Manage Tickers

OLMA Olema Pharmaceuticals, Inc.

Nasdaq olema.com


$ 22.26 $ 1.75 (8.55 %)    

Thursday, 20-Nov-2025 15:07:40 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 589.80 $ -21.87 (-3.58 %)
DIA $ 460.00 $ -6.68 (-1.43 %)
SPY $ 656.44 $ -16.46 (-2.45 %)
TLT $ 89.19 $ 0.20 (0.22 %)
GLD $ 375.29 $ 0.11 (0.03 %)
$ 19.43
$ 20.55
$ 22.24 x 300
$ 22.27 x 12
$ 20.04 - $ 24.81
$ 2.86 - $ 27.17
18,827,900
na
1.67B
$ 1.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-13-2025 03-31-2025 10-Q
4 03-18-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-11-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-09-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 02-28-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-10-2021 06-30-2021 10-Q
19 05-11-2021 03-31-2021 10-Q
20 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
11/20/2025 17:05:50

nutex-health-posts-strong-q3-results-joins-pacs-group-walmart-cerence-and-other-big-stocks-moving-higher-on-thursday
Nutex Health Posts Strong Q3 Results, Join...
11/20/2025 16:36:00

update-olema-oncology-announces-pricing-of-190m-public-offering-of-10m-shares-of-common-stock-at-a-price-of-19share
UPDATE: Olema Oncology Announces Pricing O...
11/19/2025 14:43:06

Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical com...

olema-oncology-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants-terms-not-disclosed
Olema Oncology Announces Proposed Public O...
11/18/2025 21:52:21

Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical com...

olema-pharmaceuticals-terminated-prospectus-related-to-sale-of-common-stock-in-at-the-market-offering-pursuant-to-sales-agreement-dated-jan-6-2025
Olema Pharmaceuticals Terminated Prospectu...
11/18/2025 21:31:31

nasdaq-down-1-medtronic-earnings-top-views
Nasdaq Down 1%; Medtronic Earnings Top Views
11/18/2025 17:53:00

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
11/18/2025 17:06:49

pharma-bro-martin-shkreli-shorts-olema-pharmaceuticals-stock
Pharma Bro Martin Shkreli Shorts Olema Pha...
11/18/2025 17:01:40

"Pharma Bro' and notorious bear Martin Shkreli is shorting Olema Pharmaceuticals stock.

hc-wainwright--co-maintains-buy-on-olema-pharmaceuticals-raises-price-target-to-36
HC Wainwright & Co. Maintains Buy on Olema...
11/18/2025 16:29:52

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and raises the price t...

oppenheimer-maintains-outperform-on-olema-pharmaceuticals-raises-price-target-to-45
Oppenheimer Maintains Outperform on Olema ...
11/18/2025 16:29:39

Oppenheimer analyst Matthew Biegler maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Outperform and raises the price tar...

jp-morgan-maintains-overweight-on-olema-pharmaceuticals-raises-price-target-to-32
JP Morgan Maintains Overweight on Olema Ph...
11/18/2025 15:38:49

JP Morgan analyst Anupam Rama maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Overweight and raises the price target fr...

amer-sports-posts-upbeat-q3-earnings-joins-diginex-james-hardie-industries--and-other-big-stocks-moving-higher-on-tuesday
Amer Sports Posts Upbeat Q3 Earnings, Join...
11/18/2025 15:10:39

cancer-focused-olema-pharmaceuticals-stock-soars-150---heres-why
Cancer Focused Olema Pharmaceuticals Stock...
11/18/2025 14:56:31

Roche posts positive phase 3 results for giredestrant in early breast cancer, showing improved disease-free survival and a favo...

dow-falls-over-300-points-home-depot-posts-downbeat-earnings
Dow Falls Over 300 Points; Home Depot Post...
11/18/2025 14:55:54

Core News & Articles
Olema Pharmaceuticals Shares Trading Highe...
11/18/2025 14:00:41

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/18/2025 12:06:25

why-gorilla-technology-shares-are-trading-higher-by-around-14-here-are-20-stocks-moving-premarket
Why Gorilla Technology Shares Are Trading ...
11/18/2025 11:10:02

olema-pharmaceuticals-q3-eps-049-misses-045-estimate
Olema Pharmaceuticals Q3 EPS $(0.49) Misse...
11/10/2025 12:17:35

Olema Pharmaceuticals (NASDAQ:OLMA) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate ...

olema-pharmaceuticals-to-present-a-trial-in-progress-poster-for-its-phase-3-opera-02-trial-at-2025-san-antonio-breast-cancer-symposium
Olema Pharmaceuticals To Present A Trial-I...
10/30/2025 20:36:13

Olema Pharmaceuticals, Inc. (("Olema" or "Olema Oncology", NASDAQ:OLMA), a clinical-stage biopharmaceutical com...

olema-pharmaceuticals-exelixis-genmab-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Olema Pharmaceuticals, Exelixis, Genmab An...
10/20/2025 12:10:45

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION